Does treatment with drug-eluting stents reduce mortality rates compared to Coronary-Artery Bypass Grafting in patients with multivessel disease?
In patients with multivessel coronary disease, CABG remains superior to drug-eluting stents in reducing mortality, myocardial infarction, and the need for repeat revascularization.
For patients with multivessel disease, CABG continues to be associated with lower mortality rates than does treatment with drug-eluting stents and is also associated with lower rates of death or myocardial infarction and repeat revascularization.
Hannan et al. (Wed,) studied this question.